Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Avonex
Active Ingredient: Interferon beta-1a 30Ág
Dosage Form: Powder for injection
New Zealand Sponsor: CSL (New Zealand) Limited
Manufacturer(s): Ben Venue Laboratories Inc, Bedford, Ohio, United States of America
Pierre Fabre Medicament Production, Etablissement Aquitaine Pharm International, Idron, France
Product: Canesten Bifonazole Once Daily Anti-Fungal Body Cream
Active Ingredient: Bifonazole 1%w/w
Dosage Form: Topical cream
New Zealand Sponsor: Bayer New Zealand Limited Health Care Division
Manufacturer: Bayer Australia Limited, Health Care Operations Centre, Mulgrave, Victoria, Australia
Product: ClinOleic
Active Ingredient(s): Olive oil 80%
Soya oil 20%
Dosage Form: Emulsion for infusion
New Zealand Sponsor: Baxter Healthcare Limited
Manufacturer: Clintec Parenteral S.A., d'Amilly, Montargis, France
Product: CMW2 Gentamicin Bone Cement
Active Ingredient: Gentamicin sulphate 2.9%w/w equivalent to 1.7%w/w gentamicin base in the prepared cement
Dosage Form: Powder component bone cement
Active Ingredient: Methylmethacrylate 99.18%w/w
Dosage Form: Liquid component bone cement
New Zealand Sponsor: DePuy New Zealand Limited
Manufacturer: DePuy CMW, Blackpool, United Kingdom
Product: Tamoxifen-BC
Active Ingredient: Tamoxifen citrate 15.2mg equivalent to 10mg tamoxifen
Dosage Form: Tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Heumann Pharma GmbH, Feucht, Germany
Product: Tamoxifen-BC
Active Ingredient: Tamoxifen citrate 30.4mg equivalent to 20mg tamoxifen
Dosage Form: Tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Heumann Pharma GmbH, Feucht, Germany
Dated this 16th day of January 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).